| Primary |
| Pain |
33.3% |
| Bone Pain |
16.7% |
| Back Pain |
11.1% |
| Chondrosarcoma |
11.1% |
| Premedication |
11.1% |
| Adenocarcinoma Gastric |
5.6% |
| Cancer Pain |
5.6% |
| Postoperative Pain |
5.6% |
|
| Lipase Increased |
20.0% |
| Disorientation |
10.0% |
| Hallucination |
10.0% |
| Intestinal Obstruction |
10.0% |
| Oedema |
10.0% |
| Rash Pustular |
10.0% |
| Respiratory Disorder |
10.0% |
| Shock |
10.0% |
| Vomiting |
10.0% |
|
| Secondary |
| Pain |
26.6% |
| Back Pain |
9.9% |
| Drug Use For Unknown Indication |
7.4% |
| Bronchial Carcinoma |
6.4% |
| Coronary Artery Disease |
6.4% |
| Hypertension |
6.4% |
| Cancer Pain |
3.9% |
| Multiple Myeloma |
3.5% |
| Status Epilepticus |
3.5% |
| Bone Pain |
3.2% |
| Post Herpetic Neuralgia |
3.2% |
| Hypothyroidism |
2.5% |
| Analgesia |
2.1% |
| Cardiac Failure |
2.1% |
| Hyperlipidaemia |
2.1% |
| Nephrogenic Anaemia |
2.1% |
| Neuralgia |
2.1% |
| Osteoarthritis |
2.1% |
| Pain In Extremity |
2.1% |
| Product Used For Unknown Indication |
2.1% |
|
| Somnolence |
16.0% |
| Sweat Gland Disorder |
12.0% |
| Pruritus |
8.0% |
| Urinary Retention |
8.0% |
| Confusional State |
6.0% |
| Hepatitis Acute |
6.0% |
| Vomiting |
6.0% |
| Weight Decreased |
6.0% |
| Hallucination, Visual |
4.0% |
| Hypotension |
4.0% |
| Renal Failure Acute |
4.0% |
| Urinary Tract Infection |
4.0% |
| Bradypnoea |
2.0% |
| Faecaloma |
2.0% |
| Ileus |
2.0% |
| Intentional Drug Misuse |
2.0% |
| Intestinal Obstruction |
2.0% |
| Oedema |
2.0% |
| Osteonecrosis |
2.0% |
| Pain |
2.0% |
|
| Concomitant |
| Pain |
15.1% |
| Drug Use For Unknown Indication |
14.6% |
| Product Used For Unknown Indication |
14.6% |
| Prophylaxis |
7.7% |
| Hypertension |
6.2% |
| Tumour Pain |
5.5% |
| Non-small Cell Lung Cancer |
5.5% |
| Analgesic Therapy |
4.2% |
| Constipation |
4.0% |
| Gastric Cancer |
2.7% |
| Rheumatoid Arthritis |
2.7% |
| Insomnia |
2.3% |
| Abdominal Pain |
2.1% |
| Prostate Cancer |
2.1% |
| Thrombosis Prophylaxis |
1.9% |
| Hypokalaemia |
1.8% |
| Constipation Prophylaxis |
1.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Hypothyroidism |
1.7% |
| Diarrhoea |
1.7% |
|
| Vomiting |
16.5% |
| Thrombocytopenia |
10.0% |
| Psychotic Disorder |
7.6% |
| Death |
6.5% |
| Renal Failure Acute |
6.5% |
| General Physical Health Deterioration |
5.9% |
| Pleural Effusion |
5.3% |
| Vertigo |
5.3% |
| Malignant Neoplasm Progression |
3.5% |
| Osteonecrosis |
3.5% |
| Pyrexia |
3.5% |
| Somnolence |
3.5% |
| Wrong Technique In Drug Usage Process |
3.5% |
| Pulmonary Embolism |
2.9% |
| Spinal Fracture |
2.9% |
| Subdural Haematoma |
2.9% |
| Weight Decreased |
2.9% |
| Circulatory Collapse |
2.4% |
| Gait Disturbance |
2.4% |
| Hyponatraemia |
2.4% |
|
| Interacting |
| Pain |
23.5% |
| Back Pain |
17.6% |
| Cancer Pain |
11.8% |
| Benign Prostatic Hyperplasia |
5.9% |
| Insomnia |
5.9% |
| Depression |
4.4% |
| Atrial Fibrillation |
2.9% |
| Drug Use For Unknown Indication |
2.9% |
| Essential Hypertension |
2.9% |
| Hyperlipidaemia |
2.9% |
| Metastatic Pain |
2.9% |
| Prophylactic Chemotherapy |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Anaemia |
1.5% |
| Anxiety |
1.5% |
| Arteriosclerosis |
1.5% |
| Atrial Flutter |
1.5% |
| Bladder Transitional Cell Carcinoma |
1.5% |
| Blood Pressure |
1.5% |
| Blood Pressure Increased |
1.5% |
|
| Respiratory Failure |
30.8% |
| Hospitalisation |
15.4% |
| Malaise |
15.4% |
| Pain |
15.4% |
| Coordination Abnormal |
7.7% |
| Ileus |
7.7% |
| Inappropriate Schedule Of Drug Administration |
7.7% |
|
